These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32184655)

  • 1. OTUD4: A Potential Prognosis Biomarker for Multiple Human Cancers.
    Zhao X; Su X; Cao L; Xie T; Chen Q; Li J; Xu R; Jiang C
    Cancer Manag Res; 2020; 12():1503-1512. PubMed ID: 32184655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OTU deubiquitinase 4 is silenced and radiosensitizes non-small cell lung cancer cells via inhibiting DNA repair.
    Wu Z; Qiu M; Guo Y; Zhao J; Liu Z; Wang H; Meng M; Yuan Z; Mi Z
    Cancer Cell Int; 2019; 19():99. PubMed ID: 31011293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic gene CRABP2 affects drug sensitivity by regulating docetaxel-induced apoptosis in breast invasive carcinoma: A pan-cancer analysis.
    Zeng S; Xu Z; Liang Q; Thakur A; Liu Y; Zhou S; Yan Y
    Chem Biol Interact; 2023 Mar; 373():110372. PubMed ID: 36736488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OTUD4 promotes the progression of glioblastoma by deubiquitinating CDK1 and activating MAPK signaling pathway.
    Ci M; Zhao G; Li C; Liu R; Hu X; Pan J; Shen Y; Zhang G; Li Y; Zhang L; Liang P; Cui H
    Cell Death Dis; 2024 Mar; 15(3):179. PubMed ID: 38429268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of suppressor of cytokine signaling proteins in human breast Cancer.
    Sun M; Tang C; Liu J; Jiang W; Yu H; Dong F; Huang C; Rixiati Y
    BMC Cancer; 2021 Jun; 21(1):696. PubMed ID: 34120621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic-Mediated Downregulation of Zinc Finger Protein 671 (
    Zhang J; Zheng Z; Zheng J; Xie T; Tian Y; Li R; Wang B; Lin J; Xu A; Huang X; Yuan Y
    Front Oncol; 2019; 9():342. PubMed ID: 31134149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of
    Zheng R; Zhu HL; Hu BR; Ruan XJ; Cai HJ
    World J Clin Cases; 2020 Jul; 8(14):2917-2929. PubMed ID: 32775374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation on the Potential Correlation Between
    Yao L; Zhong X; Huang G; Ma Q; Xu L; Xiao H; Guo X
    Front Cell Dev Biol; 2021; 9():730337. PubMed ID: 34778250
    [No Abstract]   [Full Text] [Related]  

  • 9. Deubiquitinating enzyme OTUD4 regulates metastasis in triple-negative breast cancer by stabilizing Snail1.
    Ma X; Wan R; Wen Y; Liu T; Song Y; Zhu Y
    Exp Cell Res; 2024 Jan; 434(1):113864. PubMed ID: 38040050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of RRM2 as an independent predictive factor of poor prognosis in patients with lung adenocarcinoma.
    Jin CY; Du L; Nuerlan AH; Wang XL; Yang YW; Guo R
    Aging (Albany NY); 2020 Dec; 13(3):3518-3535. PubMed ID: 33411689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
    Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K
    Gene; 2019 Oct; 716():144025. PubMed ID: 31394177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xanthine dehydrogenase as a prognostic biomarker related to tumor immunology in hepatocellular carcinoma.
    Lin Z; Xie YZ; Zhao MC; Hou PP; Tang J; Chen GL
    Cancer Cell Int; 2021 Sep; 21(1):475. PubMed ID: 34496841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
    Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY
    Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma.
    Su J; Huang Y; Wang Y; Li R; Deng W; Zhang H; Xiong H
    Cancer Cell Int; 2022 Feb; 22(1):67. PubMed ID: 35139863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnostic or prognostic values of FADD in cancers based on pan‑cancer analysis.
    Wang C; Jiang X; Zhao Q; Xie Z; Cai H
    Biomed Rep; 2023 Nov; 19(5):77. PubMed ID: 37829257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
    Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
    BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNASE1L3 as a Prognostic Biomarker Associated with Immune Cell Infiltration in Cancer.
    Deng Z; Xiao M; Du D; Luo N; Liu D; Liu T; Lian D; Peng J
    Onco Targets Ther; 2021; 14():2003-2017. PubMed ID: 33776450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancancer Analysis of the Oncogenic and Prognostic Role of
    Liu Q; Xie R; Li Y
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and prognosis analysis of
    Li H; Li Q; Jing H; Zhao J; Zhang H; Ma X; Wei L; Dai R; Sun W; Suo Z
    Front Biosci (Landmark Ed); 2021 Oct; 26(10):707-716. PubMed ID: 34719199
    [No Abstract]   [Full Text] [Related]  

  • 20. Comprehensive Analysis of Immune Implication and Prognostic Value of
    Zeng Y; Zhang Z; Chen H; Fan J; Yuan W; Li J; Zhou S; Liu W
    Front Oncol; 2021; 11():798425. PubMed ID: 35047409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.